Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience

Br J Haematol. 2020 Feb;188(4):e57-e60. doi: 10.1111/bjh.16324. Epub 2019 Dec 2.

¹ Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
² Department of Haematology, Wycombe General Hospital, High Wycombe, UK.
³ Department of Haematology, Royal Berkshire Hospital NHS Foundation Trust, Reading, UK.
⁴ Department of Haematology, Great Western Hospital, Swindon, UK.
⁵ Department of Haematology, Wexham Park Hospital, Slough, UK.
⁶ Department of Haematology, Milton Keynes Hospital, Milton Keynes, UK.
⁷ Department of Haematology, Frimley Park Hospital, Frimley, UK.

No abstract available

Keywords: carfilzomib; dose intensity; myeloma.

Publication types